| 1991 | Intron-A | Interferon-alfa-2b |
|
| 1996 | Roferon-A | Interferon-alfa-2a |
|
| 1997 | Infergen | Concensus Interferon |
|
|
| All Standard Interferon SVR Rates (approximately): | Genotype 1 (9%)
Genotype 2, 3 (30%) |
| 1998 | Rebetron | Intron-A plus Ribavirin | Genotype 1 (29%)
Genotype 2, 3 (62%) |
| 2001 | Peg-Intron | PegInterferon-alfa-2b | Genotype 1 (14%)
Genotype 2, 3 (47%) |
| 2001 | Peg-Intron / Ribavirin | PegInterferon-alfa-2b / Ribavirin | Genotype 1 (41%)
Genotypes 2—6 (75%) |
| 2002 | Pegasys | PegInterferon-alfa-2a | Genotype 1 (28%)
Genotype 2, 3 (56%) |
| 2003 | Pegasys / Ribavirin | Pegylated alfa-2a / Ribavirin | Genotype 1 (51%)
Genotypes 2—6 (70%)
Genotype 2, 3 (82%) |
| 2011 | Victrellis / PEG / RBV | Boceprevir / PEG / RBV | Genotype 1 (66%) |
| 2011 | Incivek / PEG / RBV | Telaprevir / PEG / RBV | Genotype 1 (79%) |
| 2013 | Olysio / PEG / RBV | Simeprevir / PEG / RBV | Genotype 1
(Up to 80%) |
| 2013 | Sovaldi / PEG / RBV | Sofosbuvir / PEG / RBV | Genotype 1 (Up to 92%)
Genotype 4 (92%) |
| 2013 | Sovaldi / RBV | Sofosbuvir / RBV | Genotype 2 (Up to 100%)
Genotype 3 (Up to 91%) |
| 2014 | Sovaldi / Olysio / RBV | Sofosbuvir / Simeprevir / RBV | Genotype 1
(Up to 92%) |
| 2014 | Harvoni | Sofosbuvir / Ledipasvir | Genotype 1
(Up to 100%) |
| 2014 | VIEKIRA PAK | Ombitasvir, Paritaprevir/Ritonavir, Dasabuvir with/without Ribavirin | Genotype 1
(Up to 100%) |
| 2015 | Daklinza | Daclatasvir for use with Sofosbuvir | Genotype 3
(Up to 98%) |
| 2015 | Technivie | Ombitasvir, Paritaprevir and Ritonavir plus Ribavirin | Genotype 4
(Up to 100%) |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.